| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
36 companies
Orbimed Advisors LLC is a Director, 10% Owner at EWTX with holdings across 36 companies. Recent SEC Form 4 filings include 10 buys and 18 sells.
Estimated insider holdings value: $2043.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 25, 2017 | KALA Kala Bio, Inc. | 10% Owner, See Remarks | Buy | 319,333 | $15.00 | $4,789,995.00 | +15.5% | |
| Mar 27, 2017 | Director | Buy | 1,190,476 | $4.20 | $4,999,999.20 | +24.0% | ||
| Mar 15, 2017 | WHWK Whitehawk Therapeutics, Inc. | Director, 10% Owner | Buy | 762,995 | $5.00 | $3,814,975.00 | +20.9% | |
| Mar 14, 2017 | GKOS Glaukos Corp | Director | Sell | 382,538 | $45.33 | $17,339,215.44 | -4.9% | |
| Mar 3, 2017 | GKOS Glaukos Corp | Director | Sell | 55,772 | $47.05 | $2,624,072.60 | -2.6% | |
| Feb 21, 2017 | SYRE Spyre Therapeutics, Inc. | 10% Owner | Buy | 109,300 | $5.16 | $563,882.00 | +2.6% | |
| Aug 12, 2016 | GKOS Glaukos Corp | Director | Sell | 292,938 | $33.69 | $9,869,285.26 | -4.2% | |
| Aug 3, 2016 | GKOS Glaukos Corp | Director | Sell | 425,000 | $30.59 | $13,000,750.00 | -14.7% | |
| Jun 27, 2016 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 550,000 | $14.00 | $7,700,000.00 | +42.5% | |
| Jun 27, 2016 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 550,000 | $14.00 | $7,700,000.00 | +42.5% |